McKesson Corp

MCK: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|<PLOCK|$^&DSLOCK|p%&p<mB

McKesson's Long-Term Strength Is Underpinned by GLP-1s, Specialty Investments, and Customer Wins

Business Strategy and Outlook

McKesson is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $300 billion in sales, the firm supplies roughly a third of the domestic drug distribution market. Together with Cardinal Health and Cencora, the three operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the US market.

Sponsor Center